The 2026 Companion Diagnostics Market: Architectural Blueprint for Bio-Digital Healthcare Convergence
In the landscape of 2026, the global medical community has shifted its primary focus from general therapeutics to a specialized, data-driven methodology. At the epicenter of this transformation is the Companion Diagnostic Market, serving as the essential bridge between a patient’s unique genetic profile and the efficacy of advanced pharmaceutical interventions. No longer an auxiliary...
0 Reacties 0 aandelen 18 Views 0 voorbeeld